Rare Disease Trial, Recruiting (NCT06343558)

Rare Disease Trial, Recruiting NCT06343558 Sponsor: Istituto Auxologico Italiano Condition: Rare Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06343558 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rare Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Multiple Sclerosis, Parkinson's disease, nerve damage in the legs (peripheral neuropathy), or a rare neurological condition (such as CANVAS or Wilson's disease)
You have a neurological condition that has not yet been identified, even after a full medical assessment
You are over 18 years old
You are able to stand up straight on your own, without any walking aids or help from another person, for more than 30 seconds
You are able to walk more than 50 metres on your own, without any walking aids or help from another person
You are able to understand and sign a consent form agreeing to take part in the trial

Who may not be able to join:

You are currently pregnant or breastfeeding
You have another medical condition that affects your balance or the way you walk on its own (for example, an amputation of a leg or weakness on one side of the body caused by a stroke)
You have had major surgery on your joints, such as a hip or knee replacement

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06343558

Sponsor: Istituto Auxologico Italiano

Phase: Not Applicable

Status: Recruiting

Condition: Rare Disease

More information: https://clinicaltrials.gov/study/NCT06343558

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Multiple Sclerosis, Parkinson's disease, nerve damage in the legs (peripheral neuropathy), or a rare neurological condition (such as CANVAS or Wilson's disease)
You have a neurological condition that has not yet been identified, even after a full medical assessment
You are over 18 years old
You are able to stand up straight on your own, without any walking aids or help from another person, for more than 30 seconds
You are able to walk more than 50 metres on your own, without any walking aids or help from another person
You are able to understand and sign a consent form agreeing to take part in the trial

Who may not be able to join:

You are currently pregnant or breastfeeding
You have another medical condition that affects your balance or the way you walk on its own (for example, an amputation of a leg or weakness on one side of the body caused by a stroke)
You have had major surgery on your joints, such as a hip or knee replacement

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Istituto Auxologico Italiano

Registry

ClinicalTrials.gov

Start date

30 May 2023

Est. completion

1 May 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Balance (Mini-BESTest); Balance (Timed Up and Go test); Gait speed; Gait analysis - kinematic - stride length; Gait analysis - kinematic - duration; Gait analysis - kinematic - width of the base of support; Gait analysis - kinematic - dorsal ankle angle; Gait analysis - dynamic - reaction force; Gait analysis - dynamic - ankle power; Gait analysis - dynamic - energy; Posturography - static - centre of pressure position; Posturography - static - centre of mass position; Posturography - dynamic - centre of pressure position; Posturography - dynamic - centre of mass position

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov